Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Bursitis epidemiology and demographics
Introduction
Overview
Overview
Bursitis accounts for 400 visits per 100,000 visits to primary care clinics. The exact prevalence and incidence of bursitis are unknown.[1]
Epidemiology and Demographics
Epidemiology and Demographics
Prevalence and Incidence
- The exact incidence and prevalence of bursitis are not known.
- The incidence of septic olecranon and prepatellar bursitis is estimated to be 10 to 100 cases per 100,000 hospital admissions.[1]
- In sport medicine practice, the incidence of trochanteric bursitis was estimated to be 560 cases per 100,000 cases.[2]
Age
- Prepatellar bursitis can affect all age groups. However, the incidence of septic bursitis is higher in children, particularly immunocompromised patients.
- Olecranon bursitis affects middle-aged people (between the ages of 30 and 60 years).
- Trochanteric bursitis can affect all age groups, though the incidence of trochanteric bursitis may be higher in middle-aged to elderly adults.[3]
Gender
- Males are more commonly affected by prepatellar bursitis and septic bursitis than women.
- Females are more commonly affected by trochanteric bursitis or greater trochanteric pain syndrome (GTPS) than male. The female to male ratio is approximately 4 to 1.[3]
Race
- There is no racial predilection to bursitis.
References
References
- ↑ 1.0 1.1 McAfee JH, Smith DL (1988). “Olecranon and prepatellar bursitis. Diagnosis and treatment”. West J Med. 149 (5): 607–10. PMC 1026560. PMID 3074561.
- ↑ Brinks A, van Rijn RM, Bohnen AM, Slee GL, Verhaar JA, Koes BW; et al. (2007). “Effect of corticosteroid injection for trochanter pain syndrome: design of a randomised clinical trial in general practice”. BMC Musculoskelet Disord. 8: 95. doi:10.1186/1471-2474-8-95. PMC 2045096. PMID 17880718.
- ↑ 3.0 3.1 Govaert LH, van Dijk CN, Zeegers AV, Albers GH (2012). “Endoscopic bursectomy and iliotibial tract release as a treatment for refractory greater trochanteric pain syndrome: a new endoscopic approach with early results”. Arthrosc Tech. 1 (2): e161–4. doi:10.1016/j.eats.2012.06.001. PMC 3678627. PMID 23766989.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]